Minute Insight: Mainz Biomed Shows Off New Colorectal Cancer Diagnostic Test Data
Executive Summary
The company’s ColoAlert mRNA-based diagnostic has proven similarly efficacious to colonoscopy, while outperforming competing blood/stool-based diagnostics.
You may also be interested in...
Exact Sciences Nails Colorectal Cancer Test Trial Ahead Of Planned Submission
Exact Sciences’ next generation of Cologuard, which could be on the market later this year, clearly outperforms its previous.
Minute Insight: Maestro Cues The Music With CE Mark For Moon Surgical
The Paris-based start-up has picked up a CE mark for the latest generation of its Maestro system, a tool designed to make laparoscopic surgery easier and safer.
Minute Insight: 15,000 Surgeries And More Funding For CMR Surgical
The UK-based company has just raised $165m support the ongoing commercialization of the Versius robotic platform.